Serological response to SARS-CoV-2 is attenuated in patients with inflammatory bowel disease and can affect immunization.

Shaghayegh Baradaran Ghavami Shabman Shahrokh Hamid Asadzadeh AghdaeiSeyed Mobin KhoramjooAzadeh Aghamohammadi SendaniNesa KazemifardTommaso Lorenzo ParigiSilivio DaneseHedieh BalaiiGhazal SherkatNasser Ebrahimi DaryaniForoogh AlborziHassan VossoughiniaMohammad Reza Zali

Published in: JGH open : an open access journal of gastroenterology and hepatology (2022)

In this study we indicated that impaired serological responses to SARS-CoV-2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.

Keyphrases

sars cov
patients with inflammatory bowel disease
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
prognostic factors
peritoneal dialysis
quality improvement
patient reported